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ECE.Inhlbltors provide an effective approach to pharmacologically block lho 
effects of endothelln in mnn, 
• Differential Effects of Protsmlne on Conductance 
and Resistsnce Arteries: Evidence of 
Hyperpolarlzlng Factor (EDHF) Release 
D,G, Cable, M,R, OeltJen, H.V, Scheff, M~yo Clinic end M~yo Foundaflen, 
Rochester, Minnesota, USA 
Background: Protamlno revorael of heparln may I~d to systemic hypoten. 
~lon eeeend~¢Y to endothellel nitric oxide (NO) mle~lse, Endothollum.derlvod 
hypsq0olerl;¢lng feeler (EDHF) Is a novel footer olessed by the ondothsltum 
The prOllOnt study compared the roleelln of vasoncllve substances from 
remten~a (100=,?.00 .m) and oonductnn~o erterles, 
Method# fmcl Results; Canine mnlstnnce comne~/~rtertes wan meunted 
In a vl~eesceple no.flow miomvassol system, end paired ~Imumflox coronnw 
arteries were studied in organ ehembem', both war0 oontragted with endotho. 
Iin.1, Pmfemlne (10-60 mgm/ml) predated rolexatlenn in both mlcmveasel 
end ¢ondu(~tence aderles (n '~ 10); maximum mlaxatlen wee 46,0 ;L 13,0% 
In re=lslnnce v~ 94,3 ~ 8.2% in conductance ndarles, Removal el the an. 
d0thellum ~boltshed relaxations to profemlno (n = B, P -. 0.05, ANOVA), 
tndomathn¢~ln (10 ~SM) did not attar rah~xetions; 462 ~. 8,5% vs 103.1 t 
?,.'1% (n = 6), L.NMMA (10 '~M) had na sheet In resistance aderies (575 
9,g%, n =, El) but attanunted ~olnxetlons incondu(~fan~e artertea (38,3 
12,0%, n ~ 8, P • 0,05), Tetmethylemmentum (chloride (TEA, 10 "~M), an 
inhibitor of ~DHF, abolished mlexattent~ n msts~en(~n arteries but had no 
effeC:t OI1 oonductenca rtertns (103,2 :t~ ~),0%, e ~ 0), Miomvease~s produced 
only mild Qentraotlens to prot0~mtno Inthr~ presence o1 TEA (max contraction 
24,5 ~l 11,4%, n ~ 6, P ,: 0,05), 
Conclusions: Pmtamlne sulfate ~eusos ond0thollum-depondent relax- 
allen of conductance adartes and mstMance edorles by different mecha- 
nisms; NO intense in large npicerdtnl vessels and EDHF release in mi. 
cmvessels, Thl~ Is the first description of EDHF release in response to 
pmtemine, As EDHF can be blacked with cnrdloplogi¢ arras1, protamine may 
generate malone1 Imbslan~:os in myocardial podus~en due to the dilation el 
conducten~'-e v ssels end concurrent constnctlon of resistance arteries, 
• Vascular Smooth Muacle Cell Proliferation 
Induced bythe Interactlon Between Serotonln 
(5H1") endMlldty Oxldlzed LOW Denslty 
Llpoproteln, laRevereed by 5HT= Receptor 
Antagonlst or Pertuasls Toxin 
S Keb~, R. P,~kela, 1". Katagm, C.R. Benedict. University of Texas, Houston. 
TX, USA 
Background: We have previously shown that mildly oxidized low density 
lipoprotoln (mox-LDL) induced vascula[ smooth muscle cell (VSMC) preht- 
eralion nnd this effect was potentiated by 5HT, We examined the pos~ible 
mechanisms for those effects. 
Methods: Growth arrested primary rabbit VSMC were incubated with 
different concentrations of LDL or mox-LDL in the presenco or absonce at 
pertussls toxin (PTX, 10 ng/ml) for 24 hrs, to,owed by incubation with 5HT (50 
.M) or with 5HT (50 ~iM) + 5HT~ receptor antagonist (LY281067, 10 ~=g/ml) 
for 24 hrS. Then 3H-thymtdine incorporated into the DNA was measured. 
Results: Beth LY 281067 and PTX reversed the mitogenic effect of 5HT, 
and the synergistic interaction between 5HT and LDL or mox-LOL on VSMC 
proliferatien. 
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Conclusion: These results suggest that a 5HT2 receptor nntegonlst fLY 
281067) can prevent ff~o proliferative ffect of 5HT and its interaction with 
LDL or mox-LDL on VSMC at sites of vascular damage. 
~ Hlrudln Don Not Prevent Platelet ActlvaUon In 
Heperln Induced Thrombooytopenlc Syndromes 
D, Famed, J, Famed, L, Yang, D, Hoppansteedt. W, Jeske, S, Haas, 
H, Messmom, Loyola University Medical Center, Maywood, IL, USA, 
Technical University of Munich, Munich, Germany 
Rncombinenf hirudln (r.H) is approved for the anticoagulant management of 
pettante with heperin induoed thmmbocytopenia (HIT), De~pito the u~o of 
potent anticoagulant drugs the modnlity rate in patients with HIT and HIT 
with thrombosis romaine high, Initial sit=dies have indicated that o~o the 
antibody mediated salivation of pletelets has storied, himdin fails to inhib,t 
the process, To investigate this affect, blood was drawn from 30 human 
VOhlntoom in htmdtn (10 i~gtml) and 3.8% citrate, Whole bloocl impedomot~t 
nnd pletelot aggregation studies were carried out using a Ix~itivo HIT serum 
pool prepared from 20 clini(~elly established HIT positive p~tiente In both the 
~ltrated and hffudini=od blood systems a strong activation ot platelnts was 
observed, Hirudin also foiled to block the ATP release from ptatetets ulx~n 
the HiT sarum/hnpenn ec;tivetien. Similarly, in the flow ¢yt0mofno studies pa. 
tionts with established HIT syndrome c;olloctod in Citr~ted 0t himd!n exhibited 
strong ~atJvetion Supplementation ofg!ycopmtein lib/Ilia receptor mhibitom 
such as ReoPro, at sublherepo(~ti~ levels (05 i~g/ml), totally inhibited the 
HiT serum induced activation at platelats. The synlhcttc GP Ilbilga inhibitive 
else Inhibited tho activation of hirud=n nl~coagulated plat0tets. These obser. 
vations clearly suggest while hirudin may provide strong anticoagutation, it 
is of limited va!uo in tho acute phase of HIT. Antiplatelet drags such as GP 
lib/Ills inhibltora may be useful in the management el such cases 
~ Effects of Phytoestmgens on Precontrected 
Rabbit Coronary Arteries 
G.A. Fqgtmo, Y..Q. Lu, P. Coffins. Imperial Co#ego of Science, Technology & 
Medicine, NatPonal Heart & Lung In.qfihlto, London, UK 
Interest n the vascular properties of phytoostrogens ts mcmastr~j, however 
their effects or' coronary srtenas am largely unknown. We theretore investi- 
gated tho vasoactive properties of the phytoestrogons genislein (G), phlomtin 
(P) and biochanm (B) on rabbit coronary artenes in wtro. Epicardial coronaq/ 
artenal nngs of male and female rabbits were suspended in organ loathe 
lor measurement of changes in isometric tension. G (10, 20. 40 .mot~_) 
induced significant relaxation of coronary artenal nngs precontracted w~th 
potassium (30 raM) m a dose-dependent manner (mean ~: SEM: 13 ~ 1.48 
:'c 3 and 100 t 3% respectively, P .  0.01). as did P (5, 10. 20, 40 ~moL'L: 
11 ± 1, 30 ~ 2, 66 ~ 2, 97 ~ 3°o), and B (1.3. 10 and 30 .reel/L; 3 ~. 1, 
12 r I, 55 ~ 4, 103 ~ 3%). There were no differences between arteries 
from male or female rabbits, with or w~thout endothelium L-NAME and ln- 
doree[hacm did not affect phytoestrogen-induced mlaxahen in nngs with an 
intact ondothellum. Glibenclamide, banum chlonde and mehtylene blue had 
no effect on phytoestrogen-induced relaxation in nngs without endothelium. 
The specific estrogen-receptor antagonist ICI 182, 780 did no1 affect the 
coronary relaxation induced by any of the phytoestmgens. Calcium conoen- 
tralion-depende~,[ contraction curves (4, 3.,5.3. 2.5 and 2 .log M calcium) m 
K ~ depolarization medium were shifted to the right after incubation wilh G 20 
.mot/L (19.3 :~ 1, 47 ± 3.1, 62 ± 2.9, 81 ± 3.3 and 88.2 ± 43% contraclton 
respectively; P .  0.001) and 40 .mob'L (7.6 ± 0.6, 18.4 ¢ 1.2, 327 ± 3.2, 
602 ± 4 and 73.3 ~ 33% contraction respectively; P ~ 0.001) in nngs with- 
out endothehum compared to control (41.2 ± 2.7, 67 ~- 1,8, 81.8 ± 1.1.98 
1.3 and 100 ~- 0% contraclton respectively). Maximal contraction was also 
reduced. We have demonstrated that the phytoestrogens genistein, phlorelln 
and biochanin induoe signilicanl, endolhelium-independent relaxation in iso- 
lated rabbit ooronary arteries. The mechanism may involve antagonism of 
calcium channels. 
~ Ab¢iximab Inhibits Release of Platelet Granule 
Constituents 
MA. Mascelli. S.J. Marciniak, ET. Lance, R.E Jordan. Centocor, Inc.. 
Malvern, PA, USA 
The effect of abciximab tc7E3 Feb, ReoPro TM) on agonist-induced platelet 
granule release (PGR) was studied, Platelet rich plasma from normal donors 
i n = 3) was treated with abciximab for 5 rain at 37°C. The platelets were 
then stm~ulated with either TRAP or ADP and aggregation was monitored 
for 4 min. ATP release was monitored during aggregation by chemi-lumi- 
nescence. After aggregation, platelets were treated with inhibitora to block 
further release, then lhe ptasma was collected, t~-thromboglobulin (tt-TG) 
and plasminogen activator inhibitor 1 (PAl-l) plasma levels were measured 
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by ELISA. Ab¢ixlmab had a dose-dependent inhibitory effect on both ~ arid 
dense PeR that paralleled the Inhibition of aggregation, Decreased PGR may 
enhance both the long and short term therapeutic benefits o! abciximab by 
minimizing mural thrembo~ formation and decreasing the amount of mitogen 
mlasse at It~ IIte Of vascular damage, 
At~xm~lb % Inl1~Mloft Of~t lOn t % Inh i~ ot ~eteaee 
G'g/mL) ATIP" P.TG t PAl.1 t 
0:5 5~3 14¢13.5 174-5.1 6~4.5  
1.5 t5 i  ?.? 24 *2~4 10 ,110  ~5.  ]'6 
2,S 54¢6§  64 t 1~,~ I~ "t" 5 3 76 * 0.9 
50 99,  t 4 1'~ ~: t:).8 07 ~ ~.5 82,  t 2 
tO0 100 ~06 ~Bt ±~0 67*33  fit ~r t7  
'TRAP(4tOa.M): t~0~(5 ~M) Data~s~ave ~: ~ ~tandard~ewatmn 
O~ne Transfer 
Sunday. March 29, 1998, 5:00 p,m.-?:00 p,m, 
Georgia Wodd Congmu Center, West Exhibit Hall Level 
Presentation Hour: 5:00 p,m.-7;00 p,m, 
~ G e t ~  Tlrlmsh~' to  the  l~ l tmonew VS~UIMuI~ Us ing 
~ l l y  I ~ n g ~  SmOOth Mul¢ le  Cells 
/~I.M. ~ ,  J.C Mo~ge, D.,~ Lalt~, K Teict~1-Kulmzewska, 
DJ. Stewae, Tenence Doemeay Heart Centre S~ M/chaers Hoep~at, 
Unemej~ o~ Toe~ Toe~ Canada 
Ba~f :  To Olcumve~ the prob~¢rm ol m vtto Vam~ectmn and avOad Ihe 
use ol viral vedo~ o~ pmfems, we sought o astatd~ ~ smooth muscte 
ceas (SMC) transleofed ex vevo could be de~t~red wa the system~: venous 
c i ~  into the ptdmo{~a~ bed. acbm~mg lOCal t[ansgene exl~es~ron m 
me lung 
Pttma~ cultures Of p~J~morraty afle w SMC's tram Fislna[ 344 
rats were labeled wilh a guomscent, m e m ~  dye (CMTMR), 
er tmnsfected w~ I~e bem-garacP.s~;e mpo~er gene ueder the comro! 
of 1he CMV md~no~/pmmoter (pCMV-p). Transfeded or labeled SMC's (5 
t o. canr.,anim~ worn de~e~d to syngenec rec~ent rats by ~ect~n 
rote the jugular veto, the a~mals were sacnfce~ at tnf.e~s 15 n-~m.,'tes to 2 
weeks later, a~d the kings excised and examined. 
ResuRs: At 15 minutes post transplantation, injected cells were detected 
mainly m the lumen of small putmona~ a.,tenes and anenoles, often in greups 
of 3 ~r more ceils. After 24 hours, labeled SMC's were found incorporated 
[,~.~ ~ vascular wall o~ pulmonary adenoles, and transgene e~pres~on 
persmtad in situ for 14 days. ~ no e'.~lence ol {mmune response and 
minimal attrition. Using se1~ole geomett'K: assumptions, d was calculated that 
al~roximately 45 ± t 6% of the trans/e~ed cells r~ntroctuced ,nto the venous 
circulation could be identified in the lungs alter 1 hour, 25 ± 9% at 24 hours, 
13 ~: 6% at 1 week and 16 ± 6%at2 weeks (n = 6-8 for each group). 
Conc/us~on: These results suggest that a cell-based strategy of ex-tm~ 
transfedmn may provKte an effectwe r~wiral gene transfer approach for the 
treatment el pu l rnonan/~tar  d~eases. 
~T0"~ Adenoviral  of  Human Renel Gene Irramder V= 
Vasopressln Receptors Improves ContractilRy in 
Cardlomyocytes 
K.-L Laugwffz, M. Ungerer. H.-J. Weig. K Kmnsbein, 1-. Sch~eberg ~ ,
K. Hoffmann, G. Schutlz t, A. Sch0mig. Deutsches Herzzentrurn and 1 
Medizinische Klinik, Technische Unn/e/~Pat Munich. Germarry; rInst~tut f~r 
Pharmakologie, FU Berlin, Germany 
BackgrourK/: In heart failure, increased concentrations of arglnine vast> 
pressin (AVP) contribute fo vasoconstriction and reduced cardiac contractil- 
ity. These effects are mediated via the V1 subtype of vasopressin receptors 
(VIR) which stimulates intracellutar IP3 accumulation. 1"he V2 subtype (V2R) 
is not expressed in the myocardium physiologically. V2R expression is re- 
smcted to the kidney, where V2R activation stimulates adenylyl cyctase. 
Overexpression of V2R in the myocardium might allow to use AVP for an 
inotropic effect via a heterologous, cAMP.coupling receptor. 
Methods: We constructed a replication-deficient edenovirus for the hue 
man V2 vasopressin receptor (AdV2R). Cardiomyoblasts were infected w~,h 
10-1000 ptu AdV2R/cefl. Expression of the recombinant V2R was assessed 
by means of 3H-AVP binding in combination with specific V1/V2 antago- 
nists. We detected a maximum V2R density of 792 • 105 fmoVmg pro*.ein, 
whereas Control virus-infected cells only showed V1R binding. Maximum 
V2R expression was reached 72 h after infection. Confocal immunofluores- 
cence laser microscopy showed V2R expression in >90% of infected cells. 
AVP inducad a 30.told cAMP increase w=th an ECS0 of 25 ~.  Reo~'~r~t.n 
V2R-expmssing, spontaneously beating m~tatat c~rd~Wocytes howed 
a 4~ increase ~n co~lractillty aflor AVP ~imulatmo 8*, an EC~0.valu~ of 
10-100 pM. 
Concfusmns. A functionally active a0~vtrus for the htlmlm V2 mceip 
tor was O:mstru~ed, After mfect~on of ¢ 8 ~ ,  AVP ~! f~ of 
V2R-expfl~lsing ~IlSl I~1 10 an if~ft~s~ o~ ifl|fa(~tl!U~lf cAMP ~t~l ip  
t,:m The heterotogous exprffil0n 0.! lh~ cAMP~mmg r~¢AC~' 
(~)rttractde mstx~n~e to AVP in cardiomyoo/t~, 
~Xlgh  FmClUen W Ultmsouncl Sntmna~ TmnmCHon 
of Pomlne Vuculaf Smooth ~ Cells/n V/~ 
A L41wne, A,F. IBftskefl t , 5,S, Francis, 0,l, TItyl~, O.C, Cfotmm~m 
DC C ~ ,  CM. Newman. Unn~emtyotSheRte~, UK: 
'P~arma~h~-s Ine. Ca, USA 
Ba¢*~nd.- Progress in va~t~klr gene II~r=Loy ha= been ~',nde~d ~ me 
tim.'ted e l i l~  alXltor 10xl¢ity Of,:, f f~t  tra~sfe¢~ll~:l leChnlqu~ qt,~l~loul'~ 
iS safe and has been shown to facd~te tran~ite¢1,,on : ?d~'ObtaLt,. , v~fa We 
I~ve mves~galed the e f t~s  of of h~lh heqmmcy ~m~,-,~__,nd on t ra rm~ 
of porane agree vascular smooth muscle celia (VSMCs) m 
~ :  SuPconfluent VSMCa (pas~ges 2-7) were t ran~ w~ 
naked or l ip (~ (Promega T~,50~vec l  luo/efatm pla=ml0 ONA 
(7.5 l,g/ml) in medium corltainmg 10% (v/v) pomme se~u~; (m~tmuou= wave 
u~t~ at 0 (control). I .  3 or 10 MHz was ~ fo~ 60 s; ~ 
actn~y wa,~ aS~lyed at 48 h and expmsse~l ~ tight un~s per ,g  ~ cell 
protein (LUIpo); (:ell cmmts ~ pe~m~ed at 0. 3. 18 and 48 h. 
Resu/ts: ~ to ultrasound at 1 MHz yras ~ w~ a ? ~  
increase in transfeofiort wd~n l~aked DNA (DNA alone 0.4 ± 0.2 LU/.o; wlffl 1 
MHz tmatmef~t 3.0 ± 20  LU/.g, p = 0.028) a~l a 3 fold enhanceme~ wflh 
l i ~ ~ m d  plasm~d (tiposome/DNA 27.6 ± 6.9 LUIpg; w~lh t MHz 
treatme~ 72.8 ± 17 LUI.9, p = 0.007). Tm-.atme~ with 3 or 10 MHz had 
no eftecl on lransleclion efficmno/. Tra~Mment with t MHz mlultad in a 41% 
reduction in celt ~ r  at 1me 48 h t~nt  comparsd with corltr~ IP < 
0,051. 
~ -  H~ freque~y ultrasound enhances translect,m of VSMCs 
~n v~'ro and may also relam VSMC pmkreralton, both des~ propaff~s m 
the co~e~d of the preve~on of ~ s .  
~ Direct DNA Injection of Vascular Endothelial 
Growth Factor Induces Angiogemmis in 
Non-P.chemtc Myocam'iurn 
A.IM. Campt>ell, J.C Monge, D.A Latler. MA. Kul~,zewskl, D.J. Stewart. 
Terrence Donnel~ Heart Centre, St. Mc.ttaal~ t .~ l ,  Unn~rsfy of 
T~ont¢X Toronta Canada 
Background. Pre~ous work has ~monstrated the ability of vascular en- 
(K~ehal gro~d'n factor (VEGF} to induce ar~oganems after direct mlectma 
of naked ptasm¢l ONA in per i l  muscle. We determined d this tech~clue 
could prmm~ an effectwe method of inwnm myocardial germ transfer. 
Meffmds: Ptasmid DNA for the 165 an~ao-acid isoform of VEGF under the 
control of the cytorne~dowus enhancer/pmmomr (pVEGF~) was inieofed 
rote the left ventncular free wall of Spragu~Dawfey rats aged 10-12 weeks. 
Contrel animals were miectad w~th eith~ plasn'~l DNA ¢x:x3tng for the fe13offer 
gene beta-gatacios~tase (pCMV-~) or wifh buffered saline. Anin~ls 
sacrificed at intervals from 48 hours fe 2 weeks and [he hearts examined. 
Results: S~gnn~cant beta-gal stamin'3 was detected 7 days after in)eCt~. 
with approximately 3-5% of the volume of the left ventrficle xpmssJrlg the 
transgene. The hears in.lacteal with pCMV-p or buffered saline demortslrated 
a 3 fold increase in the numl0er of vessels along ~ course of ff~ needle tract 
and a 6 fold increase in the total vessel area as compared to non-lnteofed 
myocardium. Hearts iniected with pVEGF~e~ demonstrated marked neova~- 
cutanzatton w~th a 4 fold increase in the fetal number of veSSels and a 15 
fold increase in the total vessel area, as ~;o~-r~.,ared to the pCMV-# injected 
hearts. By 14 dayS after miec~on the number and total area ot vessels had 
decreased to non-injected control evels in e q animals, 
ConcluSiOn: These results indicate that direct myocardial in lucti¢,n of pies- 
mid DNA is an effective method of in.wvocjene transfer, and transfection with 
VEGF induCeS signdtcant but transient neovescularization of non-ischemic 
myocardium, greater than that seen w~th needle trauma alone. 
